STOCK TITAN

Medline (MDLN) director shifts over 577,000 Class A shares

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Medline Inc. director Patrick J. Healy reported internal restructuring transactions involving Class A common stock, not open-market buying or selling. The filing shows a distribution in kind from investment funds affiliated with Hellman & Friedman to Healy and a related family trust.

After these transactions, Healy holds 1,208,159 Class A shares directly and 150,039 shares indirectly through a family trust, with an additional 39,189 shares held indirectly through a children's trust. The trusts are for the benefit of certain family members, and Healy disclaims beneficial ownership of those trust-held shares except to the extent of his pecuniary interest.

Positive

  • None.

Negative

  • None.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
HEALY PATRICK J

(Last) (First) (Middle)
C/O HELLMAN & FRIEDMAN LLC
415 MISSION STREET, SUITE 5700

(Street)
SAN FRANCISCO CA 94105

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Medline Inc. [ MDLN ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
03/10/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Class A Common Stock 03/10/2026 J(1) 507,844 A (1) 1,208,159 D
Class A Common Stock 03/10/2026 J(1) 69,666 A (1) 150,039 I By a family trust(2)
Class A Common Stock 39,189 I By a children's trust(3)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Represents a distribution in kind of shares of the Class A common stock of Medline Inc. ("Class A Common Stock") previously held directly by Hellman & Friedman Capital Partners X (Parallel), L.P., HFCP X (Parallel - A), L.P., and Mend Investment Holdings I, L.P. in relation to the Reporting Person's and a family trust's respective indirect interests in such distributing entities.
2. Represents shares of Class A Common Stock beneficially owned indirectly by the Reporting Person through a trust for the benefit of certain of the Reporting Person's family members. The Reporting Person disclaims beneficial ownership of the shares of Class A Common Stock held by the trust, except to the extent of his pecuniary interest therein.
3. Represents shares of Class A Common Stock beneficially owned indirectly by the Reporting Person through a trust for the benefit of certain of the Reporting Person's family members. The Reporting Person disclaims beneficial ownership of the shares of Class A Common Stock held by the trust, except to the extent of his pecuniary interest therein.
/s/ Patrick J. Healy 03/12/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions did Medline (MDLN) director Patrick J. Healy report?

Patrick J. Healy reported restructuring transactions in Medline Class A common stock. They reflect a distribution in kind from investment funds to him and a family trust, rather than open-market purchases or sales, and are coded as other acquisitions or dispositions.

How many Medline (MDLN) shares does Patrick J. Healy hold directly after the Form 4?

Following the reported transactions, Patrick J. Healy directly holds 1,208,159 shares of Medline Class A common stock. This direct position reflects the in-kind distribution from affiliated investment funds and is separate from additional indirect holdings through family trusts.

What indirect Medline (MDLN) holdings does Patrick J. Healy report through family trusts?

Healy reports 150,039 Medline Class A shares held indirectly through a family trust and 39,189 shares through a children's trust. Both trusts benefit certain family members, and he disclaims beneficial ownership of those shares except to the extent of his pecuniary interest.

Did the Medline (MDLN) Form 4 show open-market buying or selling by Patrick J. Healy?

The Form 4 does not show open-market buying or selling by Healy. The transactions are coded as “J” for other acquisition or disposition, reflecting an in-kind distribution and restructuring of holdings rather than purchases or sales on the open market.

What is the nature of the restructuring noted in Medline (MDLN) director Healy’s Form 4?

The restructuring reflects an in-kind distribution of Medline Class A shares previously held by certain Hellman & Friedman-related funds. Shares were distributed to Healy and a family trust corresponding to their indirect interests in those distributing entities, changing how the holdings are structured.
MEDLINE INC

NASDAQ:MDLN

View MDLN Stock Overview

MDLN Rankings

MDLN Latest News

MDLN Latest SEC Filings

MDLN Stock Data

34.26B
216.03M
Medical Instruments & Supplies
Surgical & Medical Instruments & Apparatus
Link
United States
NORTHFIELD